OPTIMÁLNÍ HLOUBKA PRO APLIKOVÁNÍ INJEKCE KOLAGENÁZY CLOSTRIDIUM HISTOLYTICUM URČENÁ SONOGRAFIÍ PŘI LÉČBĚ DUPUYTRENOVY KONTRAKTURY

Stáhnout PDF

Autoři: I. Nagura ¹; T. Kanatani ²; Y. Harada ²; A. Inui ³; Y. Mifune ³; R. Kuroda ³; S. Lucchina ^4,5
Působiště autorů: Department of Orthopedic Surgery, Ako City Hospital, Ako, Japan ¹; Department of Orthopedic Surgery, Kobe Rosai Hospital, Kobe, Japan ²; Department of Orthopedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan ³; Locarno Hand Center, Locarno, Switzerland ⁴; Hand Unit – Locarno’s Regional Hospital, Locarno, Switzerland ⁵
Vyšlo v časopise: ACTA CHIRURGIAE PLASTICAE, 62, 3-4, 2020, pp. 64-67

Zdroje

1. Badalamente MA., Stern L., Hurst LC . The pathogenesis of Dupuytren‘s contracture: contractile mechanisms of the myofibroblasts. J Hand Surg Am. 1983, 8, 235–43.

2. Crean SM., Gerber RA., Le Graverand MP., Boyd DM., Cappelleri JC. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren’s contracture in European patients: a structured review of published studies. J Hand Surg Eur. 2011, 36:396–407.

3. Dias JJ., Braybrooke J. Dupuytren´s contracture: an audit of the outcomes of surgery. J Hand Surg Br. 2006, 31:514–21.

4. Watt AJ., Curtin CM., Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren’s disease: 8-year follow-up. J Hand Surg Am. 2010, 35:534–9.

5. Rodrigues JN., Zhang W., Scammell BE., et al. Functional outcome and complications following surgery for Dupuytren’s disease: a multi-centre cross-sectional study. J Hand Surg Eur. 2017, 42:7–17.

6. Coert JH., Nérin JP., Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006, 57:13–7.

7. Gilpin D., Coleman S., Hall S., Houston A., Karrasch J., Jones N. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg Am. 2010, 35:2027–38.e1.

8. Hurst LC., Badalamente MA., Hentz VR., Hotchkiss RN., Kaplan FT., Meals RA., Smith TM., Rodzvilla J. CORD I Study Group. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med. 2009, 361:968–79.

9. Desai SS., Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am. 2011, 36:936–42. doi: 10.1016/j.jhsa.2011.03.002.PMID: 21527148.

10. Badalamente MA., Hurst LC., Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren’s disease. J Hand Surg Am. 2002, 27:788–98.

11. Sakai A., Zenke Y., Menuki K., Yamanaka Y., Tajima T., Tsukamoto M., Uchida S. Short-term efficacy and safety of collagenase injection for Dupuytren’s contracture: Therapy protocol for successful outcomes in a clinical setting.J Orthop Sci. 2019, 24:434–40.

12. Zhang AY., Curtin CM., Hentz VR. Flexor tendon rupture after collagenase injection for Dupuytren contracture: case report. J Hand Surg Am. 2011, 36:1323–5.

13. Xiaflex_ (collagenase clostridium histolyticum) [prescribing information]. Chesterbrook, PA: Auxilium Pharmaceuticals, Inc.; October 2014.

14. Leclère FM., Mathys L., Vögelin E. [Collagenase injection in Dupuytren´s disease, evaluation of the ultrasound assisted technique].Chir Main. 2014, 33:196–203.

15. Badalamente MA., Hurst LC., Benhaim P., Cohen BM. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials. J Hand Surg Am. 2015, 40:975–83.

16. Peimer CA., Blazar P., Coleman S., Kaplan FT., Smith T., Lindau T. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data. J Hand Surg Am. 2015, 40:1597–1605.

17. Witthaut J., Jones G., Skrepnik N., Kushner H., Houston A., Lindau TR. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg Am. 2013, 38:2–11.

18. Gaston RG., Larsen SE., Pess GM., Coleman S., Dean B., Cohen BM., Kaufman GJ., Tursi JP., Hurst LC. The efficacy and safety of concurrent collagenase clostridium histolyticum injection for 2 Dupuytren contractures in the same hand; a prospective, multicentre study. J Hand Surg Am. 2015, 40, 2015, 1963–71.

19. Skov ST., Bisgaard T., Søndergaard P., Lange J. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial. J Hand Surg Am. 2017, 42:321–8.e3.

20. Verheyden JR. Early outcomes of a sequential series of 144 patients with Dupuytren contracture treated by collagenase injection using an incresed dose, multi-cord tequnique. J Hand Surg Eur. 2015, 40:133–40.

21. Meals RA., Hentz VR. Technical tips for collagenase injection treatment for Dupuytren contracture. J Hand Surg Am. 2014, 39:1195–1200.

22. Creteur V., Madani A., Gosset N. Ultrasound imaging of Dupuytren’s contracture. J Radiol. 2010, 91:687–91.

23. Morris G., Jacobson JA., Kalume Brigido M., Gaetke-Udager K., Yablon CM., Dong Q. Ultrasound features of palmar fibromatosis or Dupuytren contracture. J Ultrasound Med. 2019, 38:387–92.

24. Uehara K., Miura T., Morizaki Y., Miyamoto H., Ohe T., Tanaka S. Ultrasonographic evaluation of displaced neurovascular bundle in Dupuytren disease. J Hand Surg Am. 2013, 38:23–8.

25. Kanatani T., Nagura I., Harada Y. Collagenase Clostridium Histolyticum Injection with Precise Needle Length Adjusted by Silicone Tube Interposition for Dupuytren Contracture. J Hand Surg Asian Pac. 2018, 23:437–9.